Works by Mallikaarjun, Suresh

Results: 22

A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2009, v. 24, n. 2, p. 145, doi. 10.1002/hup.999

By:

Schieber, Frank C.;
Boulton, David W.;
Balch, Alfred H.;
Croop, Robert;
Mallikaarjun, Suresh;
Benson, Jeannine;
Carlson, Berit X

Publication type:

Article

Cytomegalovirus Antibody Responses Associated With Increased Risk of Tuberculosis Disease in Ugandan Adults.

Published in:

Journal of Infectious Diseases, 2020, v. 221, n. 7, p. 1127, doi. 10.1093/infdis/jiz581

By:

Stockdale, Lisa;
Nash, Stephen;
Farmer, Ruth;
Raynes, John;
Mallikaarjun, Suresh;
Newton, Robert;
Fletcher, Helen A

Publication type:

Article

Cytomegalovirus Antibody Responses Associated With Increased Risk of Tuberculosis Disease in Ugandan Adults.

Published in:

2020

By:

Stockdale, Lisa;
Nash, Stephen;
Farmer, Ruth;
Raynes, John;
Mallikaarjun, Suresh;
Newton, Robert;
Fletcher, Helen A

Publication type:

journal article

Absolute bioavailability of tolvaptan and determination of minimally effective concentrations in healthy subjects.

Published in:

International Journal of Clinical Pharmacology & Therapeutics, 2012, v. 50, n. 2, p. 150, doi. 10.5414/CP201621

By:

Shoaf, Susan E.;
Bricmont, Patricia;
Mallikaarjun, Suresh

Publication type:

Article

In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2011, v. 51, n. 5, p. 761, doi. 10.1177/0091270010376193

By:

Shoaf, Susan E.;
Ohzone, Yoshihiro;
Ninomiya, Shin-ichi;
Furukawa, Masayuki;
Bricmont, Patricia;
Kashiyama, Eiji;
Mallikaarjun, Suresh

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, and Safety of Tolvaptan, a Nonpeptide AVP Antagonist, During Ascending Single-Dose Studies in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 12, p. 1498, doi. 10.1177/0091270007307877

By:

Shoaf, Susan E.;
Zhao Wang;
Bricmont, Patricia;
Mallikaarjun, Suresh

Publication type:

Article

Pharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate.

Published in:

Journal of Clinical Pharmacology, 2005, v. 45, n. 1, p. 89, doi. 10.1177/0091270004269870

By:

Citrome, Leslie;
Josiassen, Richard;
Bark, Nigel;
Salazar, Daniel E.;
Mallikaarjun, Suresh

Publication type:

Article

Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers.

Published in:

Journal of Clinical Pharmacology, 2004, v. 44, n. 2, p. 179, doi. 10.1177/0091270003261901

By:

Suresh Mallikaarjun;
Daniel E. Salazar;
Steven L. Bramer

Publication type:

Article

Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.

Published in:

Current Medical Research & Opinion, 2013, v. 29, n. 10, p. 1241, doi. 10.1185/03007995.2013.821973

By:

Potkin, Steven G.;
Raoufinia, Arash;
Mallikaarjun, Suresh;
Bricmont, Patricia;
Peters-Strickland, Timothy;
Kasper, William;
Baker, Ross A.;
Eramo, Anna;
Sanchez, Raymond;
McQuade, Robert

Publication type:

Article

Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2012, v. 73, n. 4, p. 579, doi. 10.1111/j.1365-2125.2011.04114.x

By:

Shoaf, Susan E.;
Bricmont, Patricia;
Mallikaarjun, Suresh

Publication type:

Article

Population-based meta-analysis of furosemide pharmacokinetics.

Published in:

Biopharmaceutics & Drug Disposition, 2014, v. 35, n. 2, p. 119, doi. 10.1002/bdd.1874

By:

Van Wart, Scott A.;
Shoaf, Susan E.;
Mallikaarjun, Suresh;
Mager, Donald E.

Publication type:

Article

Population-based meta-analysis of hydrochlorothiazide pharmacokinetics.

Published in:

Biopharmaceutics & Drug Disposition, 2013, v. 34, n. 9, p. 527, doi. 10.1002/bdd.1863

By:

Van Wart, Scott A.;
Shoaf, Susan E.;
Mallikaarjun, Suresh;
Mager, Donald E.

Publication type:

Article

Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosis.

Published in:

Biopharmaceutics & Drug Disposition, 2013, v. 34, n. 6, p. 336, doi. 10.1002/bdd.1849

By:

Van Wart, Scott A.;
Shoaf, Susan E.;
Mallikaarjun, Suresh;
Mager, Donald E.

Publication type:

Article

Population Pharmacokinetic Modeling and Exposure‐Response Analysis for Aripiprazole Once Monthly in Subjects With Schizophrenia.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 150, doi. 10.1002/cpdd.1022

By:

Wang, Xiaofeng;
Raoufinia, Arash;
Bihorel, Sébastien;
Passarell, Julie;
Mallikaarjun, Suresh;
Phillips, Luann

Publication type:

Article

Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function.

Published in:

Kidney International, 2014, v. 85, n. 4, p. 953, doi. 10.1038/ki.2013.350

By:

Shoaf, Susan E;
Bricmont, Patricia;
Mallikaarjun, Suresh

Publication type:

Article

An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia.

Published in:

PharmacoEconomics, 2022, v. 40, n. 1, p. 121, doi. 10.1007/s40273-021-01077-8

By:

Piena, Marjanne A.;
Houwing, Natalie;
Kraan, Carla W.;
Wang, Xiaofeng;
Waters, Heidi;
Duffy, Ruth A.;
Mallikaarjun, Suresh;
Bennison, Craig

Publication type:

Article

Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole.

Published in:

2008

By:

Mallikaarjun S;
Shoaf SE;
Boulton DW;
Bramer SL;
Mallikaarjun, Suresh;
Shoaf, Susan E;
Boulton, David W;
Bramer, Steven L

Publication type:

journal article

Effects of Hepatic or Renal Impairment on Pharmacokinetics of Aripiprazole.

Published in:

Clinical Pharmacokinetics, 2008, v. 47, n. 8, p. 533, doi. 10.2165/00003088-200847080-00003

By:

Mallikaarjun, Suresh;
Shoaf, Susan E.;
Boulton, David W.;
Bramer, Steven L.

Publication type:

Article

Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia.

Published in:

2008

By:

Boulton DW;
Kollia G;
Mallikaarjun S;
Komoroski B;
Sharma A;
Kovalick LJ;
Reeves RA;
Boulton, David W;
Kollia, Georgia;
Mallikaarjun, Suresh;
Komoroski, Bernard;
Sharma, Anjali;
Kovalick, Lawrence J;
Reeves, Richard A

Publication type:

journal article

Pharmacokinetics and Tolerability of Intramuscular, Oral and Intravenous Aripiprazole in Healthy Subjects and in Patients with Schizophrenia.

Published in:

Clinical Pharmacokinetics, 2008, v. 47, n. 7, p. 475, doi. 10.2165/00003088-200847070-00004

By:

Boulton, David W.;
Kollia, Georgia;
Mallikaarjun, Suresh;
Komoroski, Bernard;
Sharma, Anjali;
Kovalick, Lawrence J.;
Reeves, Richard A.

Publication type:

Article

Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 12, p. 1595, doi. 10.1007/s00228-012-1295-5

By:

Shoaf, Susan;
Kim, Seong;
Bricmont, Patricia;
Mallikaarjun, Suresh

Publication type:

Article

Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 2, p. 207, doi. 10.1007/s00228-011-1106-4

By:

Shoaf, Susan;
Mallikaarjun, Suresh;
Bricmont, Patricia

Publication type:

Article